Sex, Drugs and Oral Cancer !
For Immediate Release For further information contact: Eleanor or Ketray 610-993-8770 email@example.com The Abrams Center for Cosmetic Dentistry is Now Offering Enhanced Oral Cancer Screenings Dr. Abrams and Dr .Amann have taken a stand against oral cancer using OralID™ Fluorescence Technology (Frazer, PA–03/11/2019 – The Abrams Center for Cosmetic dentistry joined forces with Forward Science, the manufacturer of OralID™, and became a member of the ID For Life™ Program to promote early detection and public awareness of oral cancer in the office. Dr.Abrams and Dr Amann will be offering enhanced oral cancer screenings during scheduled appointments to new and current patients. Oral Cancer is not a rare disease and unfortunately it is on the rise. This year, approximately 51,540 will be diagnosed with oral cancer in the United States alone. Due to late stage discovery one American dies every hour from oral cancer. Dr.Abrams and Dr.Amann will be using an oral cancer screening device, OralID, in efforts to discover oral cancers in their earliest stages. Currently, up to 70% of oral cancers are found in late stages (stage III, IV), resulting in a 5-year survival rate of less than 50%. OralID has the ability to “highlight” these abnormalities in much earlier stages, before it is actually visible to your dental professional, in turn increasing the 5-year survival rate up to 80-90%. Dr. Abrams and Dr. Amann has recognized the benefit of the Fluorescence Technology that OralID provides in efforts to discover oral cancer in its early stages and potentially save lives. Those interested in receiving an oral cancer screening at The Abrams Center for Cosmetic Dentistry, or to learn more about our advanced screening, contact our office at 610-993-8770 and ask about our OralID screenings, or visit our website: abramscosmeticdentistry.com About Forward Science Forward Science is a privately held biotechnology company based in Houston, Texas. OralID, Forward Science’s flagship product, is an award winning oral cancer screening device that allows clinicians to discover abnormalities that may not be seen under traditional white light examinations. Forward Science quickly expanded its product portfolio in efforts to provide clinicians with a complete program to battle the rising trends of oral cancer. With the launch of the ID For Life™ Program, Forward Science has evolved into the industry leader for oral oncology. The ID For Life™ Program includes the following in an effort to change the trends for oral cancer: screening device (OralID), diagnostic tests (CytID, PathID, hpvID, phID), and treatment options (SalivaMAX). To learn more about OralID, or any of Forward Science’s products, please visit www.ForwardScience.com or call 855-696-7254.